共 50 条
- [2] Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2625 - 2638
- [7] A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus CANCER MEDICINE, 2023, 12 (16): : 16805 - 16814
- [8] Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features CANCER MEDICINE, 2023, 12 (10): : 11315 - 11333